Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?

Neural transplantation is a potential therapeutic method for Parkinson’s disease (PD). Fetal dopaminergic (DA) neurons have been important transplantation cell sources in the history of replacement therapy for PD. Several decades of preclinical animal experiments and clinical trials using fetal DA n...

Full description

Bibliographic Details
Main Authors: Jia-Yi Li, Wen Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.666675/full
id doaj-a660a87f78d84555a78d19f1217c76fb
record_format Article
spelling doaj-a660a87f78d84555a78d19f1217c76fb2021-05-13T05:06:58ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-05-01910.3389/fcell.2021.666675666675Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?Jia-Yi Li0Jia-Yi Li1Wen Li2Wen Li3Laboratory of Neurodegenerative Diseases and Repair, Institute of Health Sciences, China Medical University, Shenyang, ChinaNeural Plasticity and Repair Unit, Wallenberg Neuroscience Centre, Department of Experimental Medical Science, Lund University, Lund, SwedenLaboratory of Neurodegenerative Diseases and Repair, Institute of Health Sciences, China Medical University, Shenyang, ChinaNeural Plasticity and Repair Unit, Wallenberg Neuroscience Centre, Department of Experimental Medical Science, Lund University, Lund, SwedenNeural transplantation is a potential therapeutic method for Parkinson’s disease (PD). Fetal dopaminergic (DA) neurons have been important transplantation cell sources in the history of replacement therapy for PD. Several decades of preclinical animal experiments and clinical trials using fetal DA neuron transplantation in PD therapy have shown not only promising results but also problems. In order to reveal possible factors influencing the clinical outcomes, we reviewed fetal DA neuron transplantation therapies from 1970s to present, with a special focus on postmortem studies. Firstly, we gave a general description of the clinical outcomes and neuroanatomy of grafted cases; secondly, we summarized the main available postmortem studies, including the cell survival, reinnervation, and pathology development. In the end, we further discussed the link between function and structure of the grafts, seeking for the possible factors contributing to a functional graft. With our review, we hope to provide references for future transplantation trials from a histological point of view.https://www.frontiersin.org/articles/10.3389/fcell.2021.666675/fullParkinson’s diseasegraftsLewy pathologypostmortem studiestransplantation
collection DOAJ
language English
format Article
sources DOAJ
author Jia-Yi Li
Jia-Yi Li
Wen Li
Wen Li
spellingShingle Jia-Yi Li
Jia-Yi Li
Wen Li
Wen Li
Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
Frontiers in Cell and Developmental Biology
Parkinson’s disease
grafts
Lewy pathology
postmortem studies
transplantation
author_facet Jia-Yi Li
Jia-Yi Li
Wen Li
Wen Li
author_sort Jia-Yi Li
title Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
title_short Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
title_full Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
title_fullStr Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
title_full_unstemmed Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
title_sort postmortem studies of fetal grafts in parkinson’s disease: what lessons have we learned?
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2021-05-01
description Neural transplantation is a potential therapeutic method for Parkinson’s disease (PD). Fetal dopaminergic (DA) neurons have been important transplantation cell sources in the history of replacement therapy for PD. Several decades of preclinical animal experiments and clinical trials using fetal DA neuron transplantation in PD therapy have shown not only promising results but also problems. In order to reveal possible factors influencing the clinical outcomes, we reviewed fetal DA neuron transplantation therapies from 1970s to present, with a special focus on postmortem studies. Firstly, we gave a general description of the clinical outcomes and neuroanatomy of grafted cases; secondly, we summarized the main available postmortem studies, including the cell survival, reinnervation, and pathology development. In the end, we further discussed the link between function and structure of the grafts, seeking for the possible factors contributing to a functional graft. With our review, we hope to provide references for future transplantation trials from a histological point of view.
topic Parkinson’s disease
grafts
Lewy pathology
postmortem studies
transplantation
url https://www.frontiersin.org/articles/10.3389/fcell.2021.666675/full
work_keys_str_mv AT jiayili postmortemstudiesoffetalgraftsinparkinsonsdiseasewhatlessonshavewelearned
AT jiayili postmortemstudiesoffetalgraftsinparkinsonsdiseasewhatlessonshavewelearned
AT wenli postmortemstudiesoffetalgraftsinparkinsonsdiseasewhatlessonshavewelearned
AT wenli postmortemstudiesoffetalgraftsinparkinsonsdiseasewhatlessonshavewelearned
_version_ 1721442802085134336